about
sameAs
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?Heterozygous deletion at the RLN1 locus in a family with testicular germ cell cancer identified by integrating copy number variation data with phenome and interactome information.Towards discovery-driven translational research in breast cancer.Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.Methods for detection of subtle mutations in cancer genomes.STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.Custom-designed MLPA using multiple short synthetic probes: application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancer.miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.MicroRNA-210, MicroRNA-331, and MicroRNA-7 Are Differentially Regulated in Treated HIV-1-Infected Individuals and Are Associated With Markers of Systemic Inflammation.MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms.Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms
P50
Q24629558-44ABCEC2-A772-4A40-90F5-D30664DA0020Q33688416-E1B0C029-7FF2-44B3-9780-6F0D99D6743CQ33940047-A0569845-6C7E-4E14-BF83-E60BE26ED8D8Q36000899-0C97F759-6FCE-4D0F-9370-266B07D270E4Q36020985-54E91692-3B93-44B1-ABF2-FD9C1850ED8EQ36641194-5BD348E3-AC3A-4976-BA22-DA1592B7AF6BQ37075919-34C4FA88-8CED-415B-8181-98C2A066C443Q37377916-92485E4D-5625-455F-AD9D-22C4EE4450FBQ38310835-0B8A5DF2-C22A-4750-A4E9-F5C43C21BDA4Q38344612-D67B1D8F-4C41-4C6E-ACC7-B73CC96750A4Q38904053-2212F76F-9C1E-4E8A-8627-9BBBD9856D97Q39586865-A223E231-E86C-4EA7-AD74-D7FF2EA750DCQ40504073-8EA81FDA-0DDC-460C-B70D-8B48ACD3DC39Q41695757-7BC1229F-9A3E-4B26-A5B8-B29C983EF6EEQ44362938-7B2C6AE9-B8FA-4ABE-8B5E-7D0EFF960EABQ46761718-531B45EB-2C24-4861-BA2B-B870ABE8AF6CQ81290124-14EA040D-EA9A-42EA-8EED-F8C76045C2F2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ulrik Ralfkiaer
@ast
Ulrik Ralfkiaer
@en
Ulrik Ralfkiaer
@es
Ulrik Ralfkiaer
@nl
Ulrik Ralfkiaer
@sl
type
label
Ulrik Ralfkiaer
@ast
Ulrik Ralfkiaer
@en
Ulrik Ralfkiaer
@es
Ulrik Ralfkiaer
@nl
Ulrik Ralfkiaer
@sl
prefLabel
Ulrik Ralfkiaer
@ast
Ulrik Ralfkiaer
@en
Ulrik Ralfkiaer
@es
Ulrik Ralfkiaer
@nl
Ulrik Ralfkiaer
@sl
P106
P21
P31
P496
0000-0003-2647-2148